Cargando…
Marginal zone B cells are responsible for the production of alloantibodies following platelet transfusion in mice
Alloimmunization against platelets remains a potentially serious adverse transfusion event. Alloantibodies produced by the recipient, mainly directed against human leukocyte antigen class I donor antigens, can compromise the therapeutic efficacy of subsequent transfusions, and may lead to refractori...
Autores principales: | Couvidou, Adèle, Angénieux, Catherine, Ruch, Laurie, Mangin, Pierre H., Gachet, Christian, Maître, Blandine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139948/ https://www.ncbi.nlm.nih.gov/pubmed/36490266 http://dx.doi.org/10.1182/bloodadvances.2022008411 |
Ejemplares similares
-
Anti-HLA Class I alloantibodies in platelet transfusion refractoriness: From mechanisms and determinants to therapeutic prospects
por: Couvidou, Adèle, et al.
Publicado: (2023) -
Discriminating young platelets on human leukocyte antigen-I expression highlights their extremely high reactivity potential
por: Angénieux, Catherine, et al.
Publicado: (2023) -
Blood utilisation and transfusion reactions in adult patients transfused with conventional or pathogen‐reduced platelets
por: Bahar, Burak, et al.
Publicado: (2019) -
Transfusion of pathogen‐reduced platelet components without leukoreduction
por: Sim, Joycelyn, et al.
Publicado: (2019) -
Expected individual benefit of prophylactic platelet transfusions in hemato‐oncology patients based on bleeding risks
por: Cornelissen, Loes L., et al.
Publicado: (2021)